Docteur MELANIE GILSON

Bibliographie

• COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection.

  2023

  ArticleJournal of Translational Autoimmunity

• COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

  2021

  ArticleThe Lancet Rheumatology

• Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

  2020

  ArticleAnnals of the Rheumatic Diseases

• Prévalence échographique des synovites et ténosynovites de la main et du pied dans la sclérodermie systémique et corrélation avec les caractéristiques de la maladie dont le handicap de la main

  2020

  ArticleRevue du Rhumatisme

• Rhumatologie interventionnelle : gestes écho-guidés

  2020

  ArticleRevue du Rhumatisme monographies

• Rheumatoid Meningitis a Rare Extra-Articular Manifestation of Rheumatoid Arthritis: Report of 6 Cases and Literature Review

  2020

  ArticleJournal of Clinical Medicine

• Ultrasound prevalence of wrist, hand, ankle and foot synovitis and tenosynovitis in systemic sclerosis, and relationship with disease features and hand disability

  2020

  ArticleJoint Bone Spine

• Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients

  2019

  ArticleRMD Open : Rheumatic & Musculoskeletal Diseases

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Localisation

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieu de consultation

• HOPITAL SUD - CHU38

  Avenue DE KIMBERLEY, 38130 Échirolles

  ☎ 0476767575Hospitalier🏥 Voir cet établissement
  © OpenStreetMap

  📷 Street View ↗🗺️ Maps ↗OSM ↗

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial

  JAMA · 2016

  📚 157 citations🎯 RCR 6.96Top 5% NIH🔓 Open Access📄 PDF gratuit ↗
• 2

  Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)

  Annals of the rheumatic diseases · 2015

  📚 106 citations🎯 RCR 5.01Top 8% NIH🩺 Clinique🔓 Open Access📄 PDF gratuit ↗
• 3

  Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study

  Arthritis research & therapy · 2010

  📚 43 citations🎯 RCR 1.58🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  AbstractIntroductionThe objective of this study was to assess natural microbial agents, history and risk factors for total joint arthroplasty (TJA) infections in patients receiving tumor necrosis factor (TNF)α-blockers, through the French RATIO registry and a case-control study.MethodsCases were TJA infections during TNFα-blocker treatments. Each case was compared to two controls (with TJA and TNFα-blocker therapy, but without TJA infection) matched on age (±15 years), TJA localization, type of rheumatic disorder and disease duration (±15 years). Statistical analyses included univariate and multivariate analyses with conditional logistic regression.ResultsIn the 20 cases (18 rheumatoid arthritis), TJA infection concerned principally the knee (n= 12, 60%) and the hip (n= 5, 25%).Staphylococcuswas the more frequent microorganism involved (n= 15, 75%). Four patients (20%) were hospitalized in an intensive care unit and two died from infection. Eight cases (40%) versus 5 controls (13%) had undergone primary TJA or TJA revision for the joint subsequently infected during the last year (P= 0.03). Of these procedures, 5 cases versus 1 control were performed without withdrawing TNFα-blockers (P= 0.08). In multivariate analysis, predictors of infection were primary TJA or TJA revision for the joint subsequently infected within the last year (odds ratio, OR = 88.3; 95%CI 1.1-7,071.6;P= 0.04) and increased daily steroid intake (OR = 5.0 per 5 mg/d increase; 1.1-21.6;P= 0.03). Case-control comparisons showed similar distribution between TNFα-blockers (P= 0.70).ConclusionsIn patients receiving TNFα-blockers, TJA infection is rare but potentially severe. Important risk factors are primary TJA or TJA revision within the last year, particularly when TNFα-blockers are not interrupted before surgery, and the daily steroid intake.

Publications scientifiques (15) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche